One Wales Medicines interim decisions

Azacitidine for progressive angioimmunoblastic T-cell lymphoma (OW16): Last review date: September 2023

Mepolizumab (Nucala®) for chronic eosinophilic pneumonia (OW15): Last review date: August 2023

Rituximab for pemphigus and pemphigoid (OW10): Last review date: July 2023

Sorafenib for acute myeloid leukaemia (AML) maintenance (OW18): Last review date: June 2023

1
2

Follow AWTTC: